Articles - Page 15 of 69 - Drugs in Context

Dermatologists’ attitude towards psoriasis treatment during the COVID-19 pandemic

Tiago Torres, Marta Pereira, Maria João Paiva Lopes, Clarisse Rebelo, Pedro Andrade, Martinha Henrique, Hugo Oliveira, Paulo Ferreira, Gabriela Marques Pinto, Francisco Menezes Brandão, Jorge Rozeira, Paulo Filipe, Rui Tavares Bello

Article Type

Original Research

Published

09 Jun 2021

This article describes the real-life strategies and therapeutic options adopted by dermatologists regarding their patients with psoriasis being treated with or with an indication for systemic therapy during the first COVID-19 lockdown period in Portugal.

Bimekizumab: the new drug in the biologics armamentarium for psoriasis

Egídio Freitas, Tiago Torres

Article Type

Editorial

Published

08 Jun 2021

Bimekizumab is mentioned in the recent report by Clarivate, Drugs to Watch in 2021, as one of the drugs to be observed in 2021. This article discusses the current status of bimekizumab.

Antidotes for childhood toxidromes

Kam Lun Hon, Wun Fung Hui, Alexander KC Leung

Article Type

Review

Published

02 Jun 2021

This is a narrative review on antidotes for toxidromes in paediatric practice.

Paediatrics: how to manage septic shock

Kam Lun Hon, Karen Ka Yan Leung, Felix Oberender, Alexander KC Leung

Article Type

Review

Published

01 Jun 2021

This article provides an updated narrative review on the management of septic shock in paediatric practice.

Paediatrics: how to manage acute respiratory distress syndrome

Kam Lun Hon, Karen Ka Yan Leung, Felix Oberender, Alexander KC Leung

Article Type

Review

Published

01 Jun 2021

The purpose of this narrative review is to provide an up-to-date review on the evaluation and management of paediatric acute respiratory distress syndrome.